Kurv Yield Premium Strategy Tesla TSLA ETF

TSLP seeks to provide current income and capped gains on the Tesla stock (TSLA) through a synthetic covered call strategy, collateralized by cash and short-term fixed-income instruments. The actively managed fund uses both standardized exchange-traded and FLEX options.

ARK 21Shares Active Bitcoin Futures Strategy ETF

YieldMax MSTR Option Income Strategy ETF

PayPal

YieldMax SQ Option Income Strategy ETF

High-yield ETFs provide investors with avenues to compensate for capital losses, if they occur at all.

5 Top-Performing Dividend ETFs of 2H Yielding At Least 20%

Tesla

ARK Industrial Innovation ETF

The Nightview Fund

GraniteShares 1.25 Long TSLA Daily ETF

Direxion Daily TSLA Bull 1.5X Shares

T-Rex 2X Long Tesla Daily Target ETF

Tradr 1.5X Long TSLA Weekly ETF

Yieldmax Tsla Option Income Etf

Simplify Volt RoboCar Disruption and Tech ETF

Consumer Discretionary Select Sector SPDR Fund

Tesla shares hit an all-time high. Several analysts raised price targets.

Tesla Stock Hits All-Time High: ETFs to Ride the Momentum

Kurv Yield Premium Strategy Apple AAPL Etf

Kurv Yield Premium Strategy Amazon AMZN ETF

Kurv Yield Premium Strategy Google GOOGL ETF

Kurv Yield Premium Strategy Microsoft MSFT ETF

Kurv Yield Premium Strategy Netflix NFLX ETF

SAN FRANCISCO--(BUSINESS WIRE)--Kurv Investment Management, an ETF provider of tax-efficient, institutional-grade investment strategies, announces the successful reorganization of its Yield Premium Suite ETFs into the Kurv ETF Trust. This transition marks a significant milestone in the company's growth and operational evolution. The Yield Premium Suite includes: Kurv Yield Premium Strategy Amazon (AMZN) ETF Kurv Yield Premium Strategy Apple (AAPL) ETF Kurv Yield Premium Strategy Google (GOOGL).

Kurv Investment Management Completes Reorganization of Yield Premium Suite to Proprietary Trust

SAN FRANCISCO--(BUSINESS WIRE)--Kurv Announces Special Distributions.

Kurv Announces Special Distributions

AstraZeneca

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca will showcase new clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the American Thoracic Society (ATS) International Conference, in San Diego, CA from May 17 - 22, 2024. The company will present 59 abstracts, including 12 late-breaking posters, with a focus on unmet needs in chronic obstructive pulmonary disease (COPD), severe asthma and eosinophilic granulomatosis with polyangiitis (EGPA).

AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio

Loncar China Biopharma ETF

Loncar Cancer Immunotherapy ETF

Parabla Innovation Etf

Advocate Rising Rate Hedge ETF

SPDR S&P 500 ETF Trust

AXS Brendan Wood TopGun Index ETF

FT Cboe Vest Laddered Moderate Buffer ETF

Simplify Developed EX-US Plus Downside Convexity

Simplify Emerging Markets Equity Plus Downside Convexity ETF

First Trust MLP & Energy Income Fund

First Trust Energy Income and Growth Fund

First Trust Energy Infrastructure Fund

First Trust New Opportunities Mlp & Energy Fund

Rayliant Quantamental Emerging Market Equity ETF

Xtrackers USD High Yield BB-B ex Financials ETF

FT Cboe Vest US Equity Moderate Buffer ETF - October

FT Cboe Vest US Equity Enhance & Moderate Buffer ETF - October

While the ETF industry didn't see over-the-top activity, the past week was fairly busy, with 11 new ETFs making their debut and six ETFs shutting down. Among the launches were two covered call funds from Goldman Sachs and a new fund from YieldMax that offers a covered call strategy tied to the stock of Moderna.

This Week in ETFs: 4 New Single-Stock Funds Debut

News for Kurv Yield Premium Strategy Tesla TSLA ETF ETF (TSLP)